Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, South Korea3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder | Recruiting | Not stated | 2025-12-01 | NCT07235709 | |
| Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice | Bacterial Infections and Mycoses, Heart Valve Prolapse, Infections, Ventricular Outflow Obstruction, aortic disorder, aortic valve disorder, aortic valve insufficiency, aortic valve stenosis, bacterial infectious disease, cardiovascular disorder, gram-positive bacterial infections, heart disorder, heart valve disorder, mitral valve insufficiency, mitral valve prolapse, rheumatic fever, rheumatic heart disease, streptococcal infection, tricuspid valve insufficiency, vascular disorder | Not yet recruiting | Not stated | 2025-07-16 | NCT07068633 | |
| ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Recruiting | Phase 4 | 2024-11-08 | NCT06580717 |